These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 8074491

  • 21. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [Abstract] [Full Text] [Related]

  • 22. Prostate carcinoma: intratumor BCG immunotherapy.
    Robinson MR, Rigby CC, Pugh RC, Dumonde DC.
    Natl Cancer Inst Monogr; 1978 Dec; (49):351-3. PubMed ID: 311894
    [Abstract] [Full Text] [Related]

  • 23. Gross and microscopic pathology of induced prostatic complex tumors arising in Lobund-Wistar rats.
    Cohen MB, Heidger PM, Lubaroff DM.
    Cancer Res; 1994 Feb 01; 54(3):626-8. PubMed ID: 7508335
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Susceptibility of Lobund-Wistar x Copenhagen hybrid rats to autochthonous prostate carcinogenesis.
    Suckow MA, Wolter W, Pollard M.
    Prostate; 2005 Jul 01; 64(2):203-8. PubMed ID: 15712219
    [Abstract] [Full Text] [Related]

  • 29. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Aug 01; 384():1-348. PubMed ID: 12692652
    [Abstract] [Full Text] [Related]

  • 30. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA, Gladu J.
    Cancer Res; 2002 Apr 15; 62(8):2390-7. PubMed ID: 11956102
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Toxicology and Carcinogenesis Studies of C.I. Acid Red 114 (CAS No. 6459-94-5) in F344/N Rats (Drinking Water Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1991 Dec 15; 405():1-236. PubMed ID: 12621513
    [Abstract] [Full Text] [Related]

  • 33. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007 Dec 15; 26 Suppl 1():3-106. PubMed ID: 17365137
    [Abstract] [Full Text] [Related]

  • 34. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2001 Jul 15; (499):7-340. PubMed ID: 12087422
    [Abstract] [Full Text] [Related]

  • 35. In vivo model systems for assessing an anti-cancer drug: responses of autochthonous and transplanted prostate tumors to cyclophosphamide.
    Pollard M, Luckert PH.
    Anticancer Res; 1990 Jul 15; 10(1):33-6. PubMed ID: 2334140
    [Abstract] [Full Text] [Related]

  • 36. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr 15; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 37. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H.
    Eur Urol; 2005 Jul 15; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 40. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO.
    Cancer Res; 2005 Nov 01; 65(21):9789-98. PubMed ID: 16267000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.